Title: Preliminary Trial of SNA014 for Pancreatic Cancer
This study is testing a new tool called **68Ga labeled Claudin 18.2**, which helps doctors see pancreatic cancer better using a special scan called **PET/CT**. This trial is for people aged 18 to 75 who have pancreatic cancer and are able to make decisions for themselves. To join, you need to have had certain tests done in the past month or year. If you have other serious health problems or are pregnant, you cannot participate.
Key Points:
- The study involves using a new contrast agent with a scan to better detect pancreatic cancer.
- Participants need to have recent medical test results and be between 18 to 75 years old.
- People with other severe health issues or who are expecting a child cannot join the study.
How understandable was the trial content above?
Hard to understand
Easy to understand